NASDAQ:HALO
Halozyme Therapeutics Stock News
$44.71
-0.680 (-1.50%)
At Close: May 17, 2024
Reviewing Eiger Biopharmaceuticals (NASDAQ:EIGR) and Halozyme Therapeutics (NASDAQ:HALO)
06:10am, Saturday, 04'th Apr 2020
Eiger Biopharmaceuticals (NASDAQ:EIGR) and Halozyme Therapeutics (NASDAQ:HALO) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength
Halozyme Announces Change Of Location Of Annual Stockholders' Meeting
12:00pm, Friday, 03'rd Apr 2020
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that due to the emerging public health impact of the coronavirus outbreak (COVID-19), to support the health and well-being of our employees a
Envestnet Asset Management Inc. Increases Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
10:42am, Thursday, 02'nd Apr 2020
Envestnet Asset Management Inc. raised its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) by 4.4% during the 4th quarter, Holdings Channel reports. The firm owned 15,010 shares of the biopharma
ValuEngine Upgrades Halozyme Therapeutics (NASDAQ:HALO) to "Buy"
09:22am, Thursday, 02'nd Apr 2020
Halozyme Therapeutics (NASDAQ:HALO) was upgraded by investment analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued on Thursday, ValuEngine reports. Severa
Zacks: Brokerages Anticipate Halozyme Therapeutics, Inc. (NASDAQ:HALO) to Post -$0.19 Earnings Per Share
10:12am, Wednesday, 01'st Apr 2020
Brokerages expect Halozyme Therapeutics, Inc. (NASDAQ:HALO) to post earnings per share (EPS) of ($0.19) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued es
Zacks: Analysts Expect Halozyme Therapeutics, Inc. (NASDAQ:HALO) Will Announce Quarterly Sales of $39.35 Million
06:56am, Tuesday, 31'st Mar 2020
Wall Street brokerages predict that Halozyme Therapeutics, Inc. (NASDAQ:HALO) will report sales of $39.35 million for the current fiscal quarter, according to Zacks Investment Research. Three analysts
Repligen (NASDAQ:RGEN) & Halozyme Therapeutics (NASDAQ:HALO) Head to Head Comparison
06:20am, Monday, 30'th Mar 2020
Repligen (NASDAQ:RGEN) and Halozyme Therapeutics (NASDAQ:HALO) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their inst
Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock?
09:44pm, Sunday, 29'th Mar 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa
Hedge Funds Were Betting On Allegheny Technologies Incorporated (ATI) Before The Coronavirus
04:12pm, Sunday, 29'th Mar 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Hedge Funds Have Never Been More Bullish On Stitch Fix, Inc. (SFIX)
12:53am, Sunday, 29'th Mar 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Hedge Funds Have Never Been More Bullish On Monro Muffler Brake Inc (MNRO)
12:53am, Sunday, 29'th Mar 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Great West Life Assurance Co. Can Makes New Investment in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
12:18pm, Saturday, 28'th Mar 2020
Great West Life Assurance Co. Can purchased a new stake in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) during the fourth quarter, according to the company in its most recent 13F filing with th
Amalgamated Bank Acquires 1,546 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)
08:54am, Friday, 27'th Mar 2020
Amalgamated Bank grew its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) by 6.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fir
Halozyme Therapeutics (HALO) Down 20.1% Since Last Earnings Report: Can It Rebound?
03:30pm, Wednesday, 25'th Mar 2020
Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Halozyme Therapeutics (HALO) Down 20.1% Since Last Earnings Report: Can It Rebound?
03:30pm, Wednesday, 25'th Mar 2020
Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.